Opioids
Opioid Bankruptcy Litigation Updates

Opioid Bankruptcy Litigation Updates

At a hearing held on April 29, 2022, a six-member panel of the Second Circuit Court of Appeals in New York was asked by lawyers representing OxyContin manufacturer Purdue Pharma to approve the bankruptcy plan submitted earlier in the year, currently estimated to be...

Litigation Update: Developments in the Current Opioid Cases

Litigation Update: Developments in the Current Opioid Cases

In a major development in the ongoing opioid litigation involving the State of New York and Nassau and Suffolk counties, on September 9 defendant manufacturer Endo Pharmaceuticals settled for $50 million. Endo reached the settlement amidst allegations that the company...

Litigation Update: Latest Opioid Litigation Developments

Litigation Update: Latest Opioid Litigation Developments

There have been a number of developments on the opioid litigation front in the last week. Drugmaker Endo Pharmaceuticals and its lawyers from Arnold & Porter are battling allegations that they withheld damaging evidence from the parties by failing to respond to...

Opioid Litigation Update

Opioid Litigation Update

Opening statements in the sprawling opioids trial pursued by the state of New York and Nassau and Suffolk counties against seven defendant manufacturers and suppliers began on June 29 with four hours of presentations. The case is the first one involving opioids to be...

Opioid Litigation Update

Opioid Litigation Update

The first bellwether trial in the sprawling multidistrict opioid litigation began on May 3 in West Virginia federal court.  The plaintiffs in the trial, Cabell County and the city of Huntington, West Virginia, which many consider the epicenter of the opioid drug...